메뉴 건너뛰기




Volumn 18, Issue 10, 2009, Pages 913-919

European attempts for the standardisation of the antiphospholipid antibodies

Author keywords

Anti 2 glycoprotein I; Anticardiolipin antibodies; Antiphospholipid antibodies; European Forum on Antiphospholipid Antibodies; Lupus anticoagulant; Standardisation

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY;

EID: 68949166321     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309106919     Document Type: Article
Times cited : (39)

References (62)
  • 1
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S Lockshin MD Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostas 2006; 4: 295-306.
    • (2006) J Thromb Haemostas , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3
  • 2
    • 0028810205 scopus 로고
    • Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH
    • Brandt JT Triplett DA Alving B Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995; 74: 1185-1190.
    • (1995) Thromb Haemost. , vol.74 , pp. 1185-1190
    • Brandt, J.T.1    Triplett, D.A.2    Alving, B.3    Scharrer, I.4
  • 3
    • 0030885477 scopus 로고    scopus 로고
    • Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome
    • Miret C Cervera R Reverter JC et al. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome. Clin Exp Rheumatol 1997; 15: 541-544.
    • (1997) Clin Exp Rheumatol , vol.15 , pp. 541-544
    • Miret, C.1    Cervera, R.2    Reverter, J.C.3
  • 4
    • 1942532181 scopus 로고    scopus 로고
    • Seronegative antiphospholipid syndrome
    • Hughes GR Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 608.
    • (2004) Ann Rheum Dis , vol.63 , pp. 608
    • Hughes, G.R.1    Khamashta, M.A.2
  • 5
    • 50249103825 scopus 로고    scopus 로고
    • The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: A personal history long in the making
    • Asherson RA. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: A personal history long in the making. Semin Thromb Hemost 2008; 34: 227-235.
    • (2008) Semin Thromb Hemost , vol.34 , pp. 227-235
    • Asherson, R.A.1
  • 6
    • 0025951058 scopus 로고
    • Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
    • Bevers EM Galli M Barbui T Comfurius P Zwaal RF. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
    • (1991) Thromb Haemost , vol.66 , pp. 629-632
    • Bevers, E.M.1    Galli, M.2    Barbui, T.3    Comfurius, P.4    Zwaal, R.F.5
  • 7
    • 0027253088 scopus 로고
    • Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism
    • Oosting JD Derksen RH Bobbink IW Hackeng TM Bouma BN de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.
    • (1993) Blood , vol.81 , pp. 2618-2625
    • Oosting, J.D.1    Derksen, R.H.2    Bobbink, I.W.3    Hackeng, T.M.4    Bouma, B.N.5    de Groot, P.G.6
  • 8
    • 1542373659 scopus 로고    scopus 로고
    • Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients
    • Cugno M Cabibbe M Galli M et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 2004; 103: 2121-2126.
    • (2004) Blood , vol.103 , pp. 2121-2126
    • Cugno, M.1    Cabibbe, M.2    Galli, M.3
  • 9
    • 0034030512 scopus 로고    scopus 로고
    • Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
    • Cugno M Dominguez M Cabibbe M et al. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome. Br J Haematol 2000; 108: 871-875.
    • (2000) Br J Haematol , vol.108 , pp. 871-875
    • Cugno, M.1    Dominguez, M.2    Cabibbe, M.3
  • 10
    • 34147213486 scopus 로고    scopus 로고
    • Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus
    • Bertolaccini ML Mepani K Sanna G Hughes GR Khamashta MA. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 533-536.
    • (2007) Ann Rheum Dis , vol.66 , pp. 533-536
    • Bertolaccini, M.L.1    Mepani, K.2    Sanna, G.3    Hughes, G.R.4    Khamashta, M.A.5
  • 11
    • 0025828109 scopus 로고
    • Guidelines for testing and revised criteria for lupus anticoagulants
    • SSC Subcommittee for the Standardization of Lupus Anticoagulants
    • Exner T Triplett DA Taberner D Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-322.
    • (1991) Thromb Haemost , vol.65 , pp. 320-322
    • Exner, T.1    Triplett, D.A.2    Taberner, D.3    Machin, S.J.4
  • 12
    • 0026072735 scopus 로고
    • Guidelines on testing for the lupus anticoagulants
    • Lupus Anticoagulant Working Party
    • Lupus Anticoagulant Working Party. Guidelines on testing for the lupus anticoagulants. J Clin Pathol 1991; 44: 885-889.
    • (1991) J Clin Pathol , vol.44 , pp. 885-889
  • 13
    • 0004750551 scopus 로고    scopus 로고
    • Guidelines of the investigation and management of the antiphospholipid syndrome
    • Greaves M Cohen H MacHin SJ Mackie I. Guidelines of the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-715.
    • (2000) Br J Haematol , vol.109 , pp. 704-715
    • Greaves, M.1    Cohen, H.2    MacHin, S.J.3    Mackie, I.4
  • 14
    • 0030982684 scopus 로고    scopus 로고
    • Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation
    • Jennings I Kitchen S Woods TA Preston FE Greaves M. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost 1997; 77: 934-937.
    • (1997) Thromb Haemost , vol.77 , pp. 934-937
    • Jennings, I.1    Kitchen, S.2    Woods, T.A.3    Preston, F.E.4    Greaves, M.5
  • 15
    • 0033035842 scopus 로고    scopus 로고
    • Lupus anticoagulant testing in Europe: An analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I
    • Arnout J Meijer P Vermylen J. Lupus anticoagulant testing in Europe: An analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Thromb Haemost 1999; 81: 929-934.
    • (1999) Thromb Haemost , vol.81 , pp. 929-934
    • Arnout, J.1    Meijer, P.2    Vermylen, J.3
  • 16
    • 0036440669 scopus 로고    scopus 로고
    • Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
    • UK National External Quality Assessment Scheme for Blood Coagulation
    • Jennings I Greaves M Mackie IJ Kitchen S Woods TA Preston FE; UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002; 119: 364-369.
    • (2002) Br J Haematol , vol.119 , pp. 364-369
    • Jennings, I.1    Greaves, M.2    Mackie, I.J.3    Kitchen, S.4    Woods, T.A.5    Preston, F.E.6
  • 17
    • 13244292384 scopus 로고    scopus 로고
    • Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: Performance in the UK NEQAS proficiency testing programme
    • UK National External Quality Assessment Scheme for Blood Coagulation
    • Jennings I Mackie I Arnout J Preston FE.; UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: Performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004; 2: 2178-2184.
    • (2004) J Thromb Haemost , vol.2 , pp. 2178-2184
    • Jennings, I.1    Mackie, I.2    Arnout, J.3    Preston, F.E.4
  • 18
    • 53049097739 scopus 로고    scopus 로고
    • A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays
    • Wong RC Favaloro EJ. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays. Semin Thromb Hemost 2008; 34: 361-372.
    • (2008) Semin Thromb Hemost , vol.34 , pp. 361-372
    • Wong, R.C.1    Favaloro, E.J.2
  • 19
    • 68949173102 scopus 로고    scopus 로고
    • Update of the guidelines for measuring the presence of Lupus Anticoagulant
    • (submitted for publication)
    • Pengo V; Tripodi A; Reber G; et al. Update of the guidelines for measuring the presence of Lupus Anticoagulant (submitted for publication).
    • Pengo, V.1    Tripodi, A.2    Reber, G.3
  • 20
    • 0026793768 scopus 로고
    • Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies
    • Galli M Comfurius P Barbui T Zwaal RFA Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
    • (1992) Thromb Haemost , vol.68 , pp. 297-300
    • Galli, M.1    Comfurius, P.2    Barbui, T.3    Zwaal, R.F.A.4    Bevers, E.M.5
  • 21
    • 0031968872 scopus 로고    scopus 로고
    • The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity - Discrimination between functional and non-function anti-prothrombin antibodies
    • Horbach DA van Oort E Derksen RHWM de Groot PG. The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity - Discrimination between functional and non-function anti-prothrombin antibodies. Thromb Haemost 1998; 79: 790-795.
    • (1998) Thromb Haemost , vol.79 , pp. 790-795
    • Horbach, D.A.1    van Oort, E.2    Derksen, R.H.W.M.3    de Groot, P.G.4
  • 22
    • 0142197160 scopus 로고    scopus 로고
    • A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants
    • Simmelink MJ Derksen RHWM Arnout JM de Groot PG. A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants. J Thromb Haemost 2003; 1: 740-747.
    • (2003) J Thromb Haemost , vol.1 , pp. 740-747
    • Simmelink, M.J.1    Derksen, R.H.W.M.2    Arnout, J.M.3    de Groot, P.G.4
  • 23
    • 3242741348 scopus 로고    scopus 로고
    • A two-step coagulation test to identify aβ2-glycoprotein I lupus antcoagulants
    • Pengo V Biasiolo A Pegoraro C Iliceto S. A two-step coagulation test to identify aβ2-glycoprotein I lupus antcoagulants. J Thromb Haemost 2004; 2: 702-707.
    • (2004) J Thromb Haemost , vol.2 , pp. 702-707
    • Pengo, V.1    Biasiolo, A.2    Pegoraro, C.3    Iliceto, S.4
  • 24
    • 7044223470 scopus 로고    scopus 로고
    • β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
    • De Laat HB Derksen RHWM Urbanus RT Roest M de Groot PG. β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004; 104: 3598-3602.
    • (2004) Blood , vol.104 , pp. 3598-3602
    • De Laat, H.B.1    Derksen, R.H.W.M.2    Urbanus, R.T.3    Roest, M.4    de Groot, P.G.5
  • 25
    • 13544276197 scopus 로고    scopus 로고
    • IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
    • De Laat B Derksen RHWM Urbanus RT de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105: 1540-1545.
    • (2005) Blood , vol.105 , pp. 1540-1545
    • De Laat, B.1    Derksen, R.H.W.M.2    Urbanus, R.T.3    de Groot, P.G.4
  • 26
    • 33846936761 scopus 로고    scopus 로고
    • Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5
    • De Laat B Wu XX van Lummel M Derksen RH de Groot PG Rand JH. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 2007; 109: 1490-1494.
    • (2007) Blood , vol.109 , pp. 1490-1494
    • De Laat, B.1    Wu, X.X.2    van Lummel, M.3    Derksen, R.H.4    de Groot, P.G.5    Rand, J.H.6
  • 27
    • 57149100983 scopus 로고    scopus 로고
    • Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C
    • De Laat B Eckmann CM van Schagen M Meijer AB Mertens K van Mourik JA. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. Blood Coagul Fibrinolysis 2008; 19: 757-764.
    • (2008) Blood Coagul Fibrinolysis , vol.19 , pp. 757-764
    • De Laat, B.1    Eckmann, C.M.2    van Schagen, M.3    Meijer, A.B.4    Mertens, K.5    van Mourik, J.A.6
  • 28
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • Galli M Luciani D Bertolini G Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-1832.
    • (2003) Blood , vol.101 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 29
    • 0036896088 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus
    • Somers E Magder LS Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2531-2536.
    • (2002) J Rheumatol , vol.29 , pp. 2531-2536
    • Somers, E.1    Magder, L.S.2    Petri, M.3
  • 30
    • 0037980219 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and pregnancy
    • Galli M Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol 2003; 16: 211-225.
    • (2003) Best Pract Res Clin Haematol , vol.16 , pp. 211-225
    • Galli, M.1    Barbui, T.2
  • 31
    • 0037111360 scopus 로고    scopus 로고
    • Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants
    • Chapman J Abu-Katash M Inzelberg R. Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci 2002; 203-204: 81-84.
    • (2002) J Neurol Sci , vol.203-204 , pp. 81-84
    • Chapman, J.1    Abu-Katash, M.2    Inzelberg, R.3
  • 32
  • 33
    • 12544253380 scopus 로고    scopus 로고
    • Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
    • Mc Laurin EY Holliday SL Williams P Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
    • (2005) Neurology , vol.64 , pp. 297-303
    • Mc Laurin, E.Y.1    Holliday, S.L.2    Williams, P.3    Brey, R.L.4
  • 34
    • 0021029327 scopus 로고
    • Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
    • Harris EN Gharavi AE Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983; 2: 1211-1214.
    • (1983) Lancet , vol.2 , pp. 1211-1214
    • Harris, E.N.1    Gharavi, A.E.2    Boey, M.L.3
  • 35
    • 0023860688 scopus 로고
    • Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders
    • Harris EN Gharavi AE Wasley GD Hughes GR. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 157: 23-31.
    • (1988) J Infect Dis , vol.157 , pp. 23-31
    • Harris, E.N.1    Gharavi, A.E.2    Wasley, G.D.3    Hughes, G.R.4
  • 36
    • 0025302635 scopus 로고
    • Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
    • Galli M Comfurius P Maassen C. et al Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
    • (1990) Lancet , vol.335 , pp. 1544-1547
    • Galli, M.1    Comfurius, P.2    Maassen, C.3
  • 37
    • 0025195938 scopus 로고
    • Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
    • Matsuura E Igarashi Y Fujimoto M Ichikawa K Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178.
    • (1990) Lancet , vol.336 , pp. 177-178
    • Matsuura, E.1    Igarashi, Y.2    Fujimoto, M.3    Ichikawa, K.4    Koike, T.5
  • 38
    • 13244255285 scopus 로고    scopus 로고
    • Should our approach to the anticardiolipin assay change 20 years after its discovery
    • Meroni PL Tincani A. Should our approach to the anticardiolipin assay change 20 years after its discovery. J Thromb Haemost 2004; 2: 1074-1076.
    • (2004) J Thromb Haemost , vol.2 , pp. 1074-1076
    • Meroni, P.L.1    Tincani, A.2
  • 40
    • 0025500242 scopus 로고
    • The second international anti-cardiolipin standardization workshop/The Kingstone anti-phospholipid antibody study (KAPS) Group
    • Harris EN. The second international anti-cardiolipin standardization workshop/The Kingstone anti-phospholipid antibody study (KAPS) Group. Am J Clin Pathol 1990; 94: 476-484.
    • (1990) Am J Clin Pathol , vol.94 , pp. 476-484
    • Harris, E.N.1
  • 41
    • 0028083763 scopus 로고
    • Fifth international symposium on antiphospholipid antibodies
    • Anticardiolipin Wet Workshop Report
    • Harris EN Pierangeli S Birch D. Anticardiolipin Wet Workshop Report. Fifth international symposium on antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616-624.
    • (1994) Am J Clin Pathol , vol.101 , pp. 616-624
    • Harris, E.N.1    Pierangeli, S.2    Birch, D.3
  • 42
    • 7044260448 scopus 로고    scopus 로고
    • Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies
    • Tincani A Allegri F Balestrieri G et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-558.
    • (2004) Thromb Res , vol.114 , pp. 553-558
    • Tincani, A.1    Allegri, F.2    Balestrieri, G.3
  • 43
    • 10744227266 scopus 로고    scopus 로고
    • Consensus guidelines on anti-cardiolipin antibody testing and reporting
    • Wong RCW Gillis D Adelstein S et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63-68.
    • (2004) Pathology , vol.36 , pp. 63-68
    • Wong, R.C.W.1    Gillis, D.2    Adelstein, S.3
  • 44
    • 0036180864 scopus 로고    scopus 로고
    • Recent advances in antiphospholipid antibodies and antiphospholipid syndrome in pediatric populations
    • Avcin T Cimaz R Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndrome in pediatric populations. Lupus 2002; 11: 4-10.
    • (2002) Lupus , vol.11 , pp. 4-10
    • Avcin, T.1    Cimaz, R.2    Meroni, P.L.3
  • 45
    • 0032499659 scopus 로고    scopus 로고
    • Antiphospholipid syndrome in the elderly: Caution
    • Piette JC Cacoub MD. Antiphospholipid syndrome in the elderly: Caution. Circulation 1998; 97: 2195-2196.
    • (1998) Circulation , vol.97 , pp. 2195-2196
    • Piette, J.C.1    Cacoub, M.D.2
  • 46
    • 0030854659 scopus 로고    scopus 로고
    • Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up
    • De Moerloose P Boehlen F Reber G Dechevrens O Herrmann F Michel JP. Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up. Age Ageing 1997; 26: 319-320.
    • (1997) Age Ageing , vol.26 , pp. 319-320
    • De Moerloose, P.1    Boehlen, F.2    Reber, G.3    Dechevrens, O.4    Herrmann, F.5    Michel, J.P.6
  • 47
    • 0034903945 scopus 로고    scopus 로고
    • Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum
    • Tincani A Allegri F Sanmarco M et al. Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-583.
    • (2001) Thromb Haemost , vol.86 , pp. 575-583
    • Tincani, A.1    Allegri, F.2    Sanmarco, M.3
  • 48
    • 33747182601 scopus 로고    scopus 로고
    • V Meeting of the European Forum on Antiphospholipid Antibodies
    • Cervera R Font J Tincani A Boffa MC. V Meeting of the European Forum on Antiphospholipid Antibodies. Autoimmun Rev 2006; 5: 499-507.
    • (2006) Autoimmun Rev , vol.5 , pp. 499-507
    • Cervera, R.1    Font, J.2    Tincani, A.3    Boffa, M.C.4
  • 49
    • 0028934121 scopus 로고
    • Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies
    • The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Estudes sur l'Hémostase et la Thrombose)
    • Reber G Arvieux J Comby E et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Estudes sur l'Hémostase et la Thrombose). Thromb Haemost 1995; 73: 444-452.
    • (1995) Thromb Haemost , vol.73 , pp. 444-452
    • Reber, G.1    Arvieux, J.2    Comby, E.3
  • 50
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for define antiphospholipid syndrome (APS)
    • Miyakis S Atsumi T Lockshin MD et al. International consensus statement on an update of the classification criteria for define antiphospholipid syndrome (APS). J Thrombos Haemostas 2006; 4: 295-306.
    • (2006) J Thrombos Haemostas , vol.4 , pp. 295-306
    • Miyakis, S.1    Atsumi, T.2    Lockshin, M.D.3
  • 51
    • 0019938113 scopus 로고
    • Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities
    • Canoso RT Sise HS. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 1982; 13: 121-129.
    • (1982) Am J Hematol , vol.13 , pp. 121-129
    • Canoso, R.T.1    Sise, H.S.2
  • 52
    • 0025028903 scopus 로고
    • Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin
    • Bevers EM Galli M. Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336: 952-953.
    • (1990) Lancet , vol.336 , pp. 952-953
    • Bevers, E.M.1    Galli, M.2
  • 53
    • 0026000561 scopus 로고
    • Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen
    • Arvieux J Roussel B Jacob MC Colomb MG. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223-229.
    • (1991) J Immunol Methods , vol.143 , pp. 223-229
    • Arvieux, J.1    Roussel, B.2    Jacob, M.C.3    Colomb, M.G.4
  • 54
    • 0036305202 scopus 로고    scopus 로고
    • Inter-laboratory variability of anti-β2-glycoprotein I measurement
    • Reber G Schousboe I Tincani A. Inter-laboratory variability of anti-β2-glycoprotein I measurement. Thromb Haemost 2002; 88: 66-73.
    • (2002) Thromb Haemost , vol.88 , pp. 66-73
    • Reber, G.1    Schousboe, I.2    Tincani, A.3
  • 55
    • 24944473169 scopus 로고    scopus 로고
    • Variability of anti-β2-glycoprotein I antibodies measurement by commercial assays
    • Reber G Tincani A Sanmarco M de Moerloose P Boffa MC. Variability of anti-β2-glycoprotein I antibodies measurement by commercial assays. Thromb Haemost 2005; 94: 665-672.
    • (2005) Thromb Haemost , vol.94 , pp. 665-672
    • Reber, G.1    Tincani, A.2    Sanmarco, M.3    de Moerloose, P.4    Boffa, M.C.5
  • 56
    • 13244292209 scopus 로고    scopus 로고
    • Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies
    • Reber G Tincani A Sanmarco M de Moerloose P Boffa MC. Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-1862.
    • (2004) J Thromb Haemost , vol.2 , pp. 1860-1862
    • Reber, G.1    Tincani, A.2    Sanmarco, M.3    de Moerloose, P.4    Boffa, M.C.5
  • 57
    • 12344309367 scopus 로고    scopus 로고
    • Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results
    • Sanmarco M Bardin N Blank M et al. Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. Thromb Haemost 2005; 93: 80-87.
    • (2005) Thromb Haemost , vol.93 , pp. 80-87
    • Sanmarco, M.1    Bardin, N.2    Blank, M.3
  • 58
    • 0030589375 scopus 로고    scopus 로고
    • The anti-β2-Glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution
    • Tincani A Spatola L Prati E et al. The anti-β2-Glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution. J Immunol 1996; 157: 5732-5738.
    • (1996) J Immunol , vol.157 , pp. 5732-5738
    • Tincani, A.1    Spatola, L.2    Prati, E.3
  • 59
    • 18844400656 scopus 로고    scopus 로고
    • Budding, vesiculation, permeabilization of phospholipids membrane-evidence for a feasible. Physiologic role of β2-glycoprotein I and pathogenic action of anti-β2-glycoprotein I antibodies
    • Ambrozic A; Bozic B; Kveder T; et al. Budding, vesiculation, permeabilization of phospholipids membrane-evidence for a feasible. Physiologic role of β2-glycoprotein I and pathogenic action of anti-β2-glycoprotein I antibodies. Biochim Biophys Acta 2005; 1740: 38-44.
    • (2005) Biochim Biophys Acta , vol.1740 , pp. 38-44
    • Ambrozic, A.1    Bozic, B.2    Kveder, T.3
  • 60
    • 7244255874 scopus 로고    scopus 로고
    • High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    • Cucnik S Kveder T Krizaj I Rozman B Bozic B. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 1478-1482.
    • (2004) Ann Rheum Dis , vol.63 , pp. 1478-1482
    • Cucnik, S.1    Kveder, T.2    Krizaj, I.3    Rozman, B.4    Bozic, B.5
  • 61
    • 28744436571 scopus 로고    scopus 로고
    • Antigenic structures recognized by anti- beta2-glycoprotein I autoantibodies
    • Kasahara H Matsura E Kaihara K et al. Antigenic structures recognized by anti- beta2-glycoprotein I autoantibodies. Int Immunol 2005; 17: 1533-1542.
    • (2005) Int Immunol , vol.17 , pp. 1533-1542
    • Kasahara, H.1    Matsura, E.2    Kaihara, K.3
  • 62
    • 62749204448 scopus 로고    scopus 로고
    • Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome
    • Rotar Z Rozman B de Groot PG et al. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome. Lupus. 2009; 18: 53-60.
    • (2009) Lupus , vol.18 , pp. 53-60
    • Rotar, Z.1    Rozman, B.2    de Groot, P.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.